title: Krill powder increases liver lipid catabolism and reduces glucose mobilization in tumor necrosis factor-alpha transgenic mice fed a high-fat diet.
abstract: A promising approach to ameliorate obesity and obesity-associated diseases is the identification of new sources of dietary ingredients. The present study investigated the hepatic regulation of energy metabolism after feeding a powder isolated from Antarctic krill (Euphausia superba) in a transgenic mouse model of chronic inflammation (human tumor necrosis factor-alpha (hTNFα) mice) known to display unfavorable effects on lipid metabolism. Male hTNFα mice were fed high-fat diets (23.6%, w/w) with or without krill powder (6.4% lipids, 4.3% protein, w/w) for 6 weeks. Blood, liver lipid, and fatty acid composition, as well as hepatic enzyme activities and gene expressions, were determined. Krill powder fed mice displayed lowered hepatic and plasma triacylglycerol levels compared to mice on a high-fat casein diet. This was accompanied by down-regulated hepatic expression of genes involved in lipogenesis and glycerolipid synthesis, and increased β-oxidation activity. In addition, the krill powder diet lowered plasma levels of cholesterol, as well as hepatic gene expression of sterol regulatory element binding transcription factor 2 (SREBP2) and enzymes involved in cholesterol synthesis. Notably, genes involved in glycolysis and gluconeogenesis were significantly reduced in liver by the krill powder diet, while genes involved in oxidative phosphorylation and uncoupling were not affected. Krill powder also reduced endogenous TNFα in liver, indicating an anti-inflammatory effect. In a high-fat mouse model with disturbed lipid metabolism due to persistent hTNFα expression, krill powder showed significant effects on hepatic glucose- and lipid metabolism, resulting in an improved lipid status in liver and plasma.
authors.affiliation: Institute of Medicine, University of Bergen, 5021 Bergen, Norway. bodil.bjorndal@med.uib.no
authors.forename: Bodil
authors.initials: B
authors.lastname: Bjørndal
authors.forename: Rita
authors.initials: R
authors.lastname: Vik
authors.forename: Trond
authors.initials: T
authors.lastname: Brattelid
authors.forename: Natalya Filipchuk
authors.initials: NF
authors.lastname: Vigerust
authors.forename: Lena
authors.initials: L
authors.lastname: Burri
authors.forename: Pavol
authors.initials: P
authors.lastname: Bohov
authors.forename: Ottar
authors.initials: O
authors.lastname: Nygård
authors.forename: Jon
authors.initials: J
authors.lastname: Skorve
authors.forename: Rolf K
authors.initials: RK
authors.lastname: Berge
mesh_terms: D000818:Animals; D001835:Body Weight; D059305:Diet, High-Fat; D004435:Eating; D033201:Euphausiacea; D005227:Fatty Acids / Q000378:metabolism; D005947:Glucose / Q000378:metabolism*; D015850:Interleukin-6 / Q000097:blood; D050356:Lipid Metabolism / Q000187:drug effects*; D008099:Liver / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D011208:Powders; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000502:physiology*
chemical_list: D005227:Fatty Acids; D015850:Interleukin-6; D011208:Powders; D014409:Tumor Necrosis Factor-alpha; D005947:Glucose